In addition to these WT rat studies, it would also be worthwhile if we could see how Bet1L serves in maintaining NMJ integrity under peripheral nerve damage and neuromuscular disorders, such as spinal ...
In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.
This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.
Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG ... and neuromuscular disease. Zilbrysq (zilucoplan), billed ...
Check out the launch trailer for Disorder, a 3D action hack-and-slash roguelike developed by Grumpy. Players will uncover a sinister truth behind a department store by fighting enemies and growing ...
In California alone, the disease struck 2,000 people between January and October last year. More than 60 infants younger than 4 months were hospitalized in the state. One died. Whooping cough ...
Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results